Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,004Revenue $M2,877Net Margin (%)-25.1Z-Score1.1
Enterprise Value $M19,987EPS $-4.9Operating Margin %-31.2F-Score4
P/E(ttm))0Cash Flow Per Share $7.2Pre-tax Margin (%)-39.1Higher ROA y-yN
Price/Book5.810-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow3.9y-y EBITDA Growth Rate %0ROA % (ttm)-7.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-32.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M154ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPGeorge Soros 2014-12-31 Buy 1.4%$60.19 - $73.37
($68.57)
$ 89.9824%New holding1,748,729
ENDPJohn Griffin 2014-12-31 Reduce-1.04%$60.19 - $73.37
($68.57)
$ 89.9824%Reduce -22.63%4,409,000
ENDPJulian Robertson 2014-12-31 Sold Out -0.37%$60.19 - $73.37
($68.57)
$ 89.9824%Sold Out0
ENDPJoel Greenblatt 2014-12-31 Sold Out -0.01%$60.19 - $73.37
($68.57)
$ 89.9824%Sold Out0
ENDPJohn Griffin 2014-09-30 Reduce-0.77%$61.26 - $70.27
($65.73)
$ 89.9827%Reduce -16.38%5,698,528
ENDPWallace Weitz 2014-09-30 Reduce-0.34%$61.26 - $70.27
($65.73)
$ 89.9827%Reduce -17.65%721,950
ENDPJoel Greenblatt 2014-09-30 Reduce-0.07%$61.26 - $70.27
($65.73)
$ 89.9827%Reduce -84.54%13,716
ENDPJohn Griffin 2014-06-30 Reduce-0.9%$56.28 - $73.94
($66.81)
$ 89.9826%Reduce -14.81%6,815,000
ENDPWallace Weitz 2014-06-30 Add0.81%$56.28 - $73.94
($66.81)
$ 89.9826%Add 75.01%876,670
ENDPJoel Greenblatt 2014-06-30 Buy 0.08%$56.28 - $73.94
($66.81)
$ 89.9826%New holding88,697
ENDPSteve Mandel 2014-06-30 Sold Out -1.2%$56.28 - $73.94
($66.81)
$ 89.9826%Sold Out0
ENDPGeorge Soros 2014-06-30 Sold Out -0.13%$56.28 - $73.94
($66.81)
$ 89.9826%Sold Out0
ENDPJulian Robertson 2014-03-31 Buy 0.51%$64.3 - $81.49
($70.78)
$ 89.9821%New holding22,800
ENDPGeorge Soros 2014-03-31 Buy 0.13%$64.3 - $81.49
($70.78)
$ 89.9821%New holding198,503
ENDPWallace Weitz 2014-03-31 Add0.12%$64.3 - $81.49
($70.78)
$ 89.9821%Add 12.33%500,920
ENDPJoel Greenblatt 2014-03-31 Sold Out -0.64%$64.3 - $81.49
($70.78)
$ 89.9821%Sold Out0
ENDPRay Dalio 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 89.9821%Sold Out0
ENDPDavid Dreman 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 89.9821%Sold Out0
ENDPSteve Mandel 2013-12-31 Buy 1.3%$43.64 - $67.25
($57.05)
$ 89.9837%New holding4,340,000
ENDPWallace Weitz 2013-12-31 Buy 1%$43.64 - $67.25
($57.05)
$ 89.9837%New holding445,920
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENDP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Farhat CamillePresident, AMS, Inc. 2015-03-10Sell8,650$89.39-1.77view
Farhat CamillePresident, AMS, Inc. 2015-03-09Sell40,438$87.020.91view
MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer 2015-03-05Sell42,033$87.780.03view
Lortie BrianPresident Branded Pharma 2015-03-04Sell5,800$85.352.88view
Upadhyay SuketuEVP, CFO 2014-11-14Buy3,700$66.9431.18view
HIGGINS ARTHUR JDirector 2014-08-05Buy3,500$65.6533.75view
DELUCCA JOHNDirector 2014-06-09Sell6,764$68.8327.58view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2014-05-29Sell175,033$72.0221.92view
DELUCCA JOHNDirector 2014-05-01Sell8,094$66.3132.42view
DELUCCA JOHNDirector 2014-04-01Sell10,384$68.4628.26view

Press Releases about ENDP :

    Quarterly/Annual Reports about ENDP:

    News about ENDP:

    Articles On GuruFocus.com
    This Week’s Pharma Highlights Mar 19 2015 
    Valeant Pharmaceuticals Goes Aggressive To Win Over Salix Mar 18 2015 
    Valeant Pharma Acquires Salix Mar 18 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
    George Soros' Top New Holdings Feb 18 2015 
    Three Pharma Majors In The Run To Acquire Salix Feb 16 2015 
    Pioneer Investments Purchases Time Warner Cable, Kohl's in Q4 Feb 10 2015 
    Larry Robbins Lives Up to Reputation for Investing in Healthcare Sector Dec 01 2014 
    Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 

    More From Other Websites
    Two Future Leaders of Specialty Pharma Mar 23 2015
    Actavis' Wide-Moat Transformation Offers Shareholder Rewards Mar 23 2015
    [$$] Proceedings: News Digest Mar 22 2015
    Dovish Fed stance lifts US stocks near records Mar 20 2015
    Salix execs – including two that resigned – to receive $78M in golden parachutes Mar 19 2015
    Valeant (VRX) Prices Shares to Finance Salix Acquisition - Analyst Blog Mar 18 2015
    The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Salix Pharmaceuticals,... Mar 18 2015
    Endo Finance Co. -- Moody's confirms Endo's Ba3 ratings; outlook stable Mar 17 2015
    Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog Mar 17 2015
    Valeant Bonds Trade Higher, Despite Skepticism Mar 17 2015
    Valeant Bumps Its Offer to $173 to Seal the Salix Deal Mar 17 2015
    For health-care stocks, buy what executives are buying Mar 17 2015
    PRESS DIGEST - Wall Street Journal - March 17 Mar 17 2015
    Valeant Wins Battle for Salix Pharmaceuticals Mar 16 2015
    Endo May Hunt Smaller Prey After Losing Out on Salix: Real M&A Mar 16 2015
    After-hours buzz: Jumei, American Air & more Mar 16 2015
    The Salix-Endo Proposal: Basics of the Transaction Mar 16 2015
    Stocks End Higher Ahead of Fed Meeting Mar 16 2015
    US stocks surge ahead of Fed meeting Mar 16 2015
    Why Valeant Had to Increase Salix Bid…and Endo Had to Walk Away Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK